Hutchison China Meditech Share Chat (HCM)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Hutchison China Meditech	LSE:HCM	London	Ordinary Share	KYG4672N1016	ORD USD1

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+50.00p	+1.34%	3,775.00p	3,760.00p	3,790.00p	3,775.00p	3,725.00p	3,725.00p	19,026	15:23:04

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	175.0	-38.3	16.2	242.9	2,292.75

Hutchison China Meditech Share Discussion Threads

Showing 1051 to 1072 of 1075 messages

Chat Pages: 43 42 41 40 39 38 37 36 35 34 33 32 Older

Date	Subject	Author	Discuss
16/8/2017 07:06	indeed! and I like the fact the Directors continue to buy dispelling any views we are over-valued. $10bn mcap Company by 2020 IMO.	nerdofsteel	Read Full Thread Reply
15/8/2017 11:59	More director buys. I tried a cheeky top up online but none available. Await the inevitable news and a £50 share price over the next couple of months	mad foetus	Read Full Thread Reply
11/8/2017 09:47	http://www.edisoninvestmentresearch.com/research/company/hutchison-china-meditech The paper on the 7th March is the most comprehensive one with regards to forecast sales numbers I do like the fact that the Company is now starting to put revenue and nett income info for each indication, starting with Fruq CRC. Others will follow as clearly the U.S Analysts expect this kind of guidance.	nerdofsteel	Read Full Thread Reply
10/8/2017 09:56	More director buys prompted me to top up just now. Gla	mad foetus	Read Full Thread Reply
10/8/2017 07:07	We are spending cash but unlike most Biotechs, at least we have a cash generating division so that means cash burn is minimal, which is also why we have not needed multiple dilutive placings over the last decade. Phase 3 trials are extremely costly but at least we will start generating cash (nett income circa $35m pa) from our first drug next year in China. As the Chairman implies, the growth in the Company's value has been substantial but the best it yet to come...	nerdofsteel	Read Full Thread Reply
09/8/2017 15:18	Ok- time will tell on the cash front. I'll try to make the agm.	dbadvn	Read Full Thread Reply
08/8/2017 18:10	I go to thw AGM every year and the Board fill me with confidence. The fact the company controlled by the richest man in Asia holds 60% is also telking IMO	nerdofsteel	Read Full Thread Reply
08/8/2017 16:28	Congratulations Nerdofsteel you can retire now ! This share is a quiet real success story, even today the herd did not pick it up. I hope you are right about the future. Cheers Hay.	haydock	Read Full Thread Reply
08/8/2017 16:19	All time high on AIM of 4100p just reached As an investor of 10 years here I can say this is now just the beginning folks! At least another 2000% over the next 10 years IMO	nerdofsteel	Read Full Thread Reply
07/8/2017 22:20	USA price about £41 now at 1.3 fx rate	nfs	Read Full Thread Reply
07/8/2017 21:33	Still holding :)	jayson26jay	Read Full Thread Reply
07/8/2017 18:07	Sharply up in US. Loving it here.	mad foetus	Read Full Thread Reply
07/8/2017 16:26	Strong finish on not much volume.	jaf1969	Read Full Thread Reply
07/8/2017 13:44	I have recently doubled up my holding following the small dip after the results. Great to see this keeping momentum.	mastermatto	Read Full Thread Reply
07/8/2017 12:45	Lots of Director buys last week on NASDAQ hxxp://www.chi-med.com/directors-share-dealing-170807/ Clearly they know exactly where the Company is heading and how it will be worth many many multiple of today's price within a few years. Love the fact that this has been co-ordinated buying by the Directors too. Their confidence is the Company can be summed up by the Chairman's comments last week:- "Simon To, Chairman of Chi-Med, said: “Chi-Med’;s consistent strategy over the past 16 years has generated considerable shareholder value, and we believe it is now poised to deliver substantially more."	nerdofsteel	Read Full Thread Reply
04/8/2017 18:17	I agree dbadvn although for me price swings are irrelevant as I've been invested and have been building a position for 10 years and will continue for the next 10 years. 2000% in the last 10 years has demonstrated that, over the long term, the Company delivers. I agree with your point about NASDAQ and US Analysts, as that is what is controlling the share price. The London listing is now irrelevant and I can see a time when they de-list as it serves no real purpose at all.	nerdofsteel	Read Full Thread Reply
04/8/2017 15:49	HCM up by 7% for a short spell on the US Nasdaq	nimrod22	Read Full Thread Reply
04/8/2017 14:13	Nerdofsteel, not disputing the history or potential. The esential difference is that the company is now dealing with NASDAQ and US analysts + fund managers . This is a different communications environment from the European/ British / far East market and patience is in much shorter supply .The short terme approach is not balanced by the long term potential. If you put something out there it has to happen and happen quickly or you will be penalised ( probably unfairly). For us private investors it does have the upside of allowing us to buy the dips , but it makes the stock more volatile than it needs to be and will put off a lot of UK funds.	dbadvn	Read Full Thread Reply
04/8/2017 07:10	Under promising and over delivering? I think you will find, if you look back through the Company's history that is exactly what the CEO has done. Also, a return of 2000% over 10 years is over delivering....,	nerdofsteel	Read Full Thread Reply
03/8/2017 21:26	Seems to be rising nicely in the US, up another 2%. Pretty positive since the results.	mad foetus	Read Full Thread Reply
03/8/2017 13:40	As I have said before whilst HCM has great potential , until it starts to make profits , the CEO needs to learn the art of underpromising and over delivering . The market will soon get tired of "leading" statements that never come to pass and will lose credibility in the future of the company. The "2 or 3 big things need to happen " and the sooner the better.	dbadvn	Read Full Thread Reply
03/8/2017 09:34	Growth over the last 10 years has been astonishing and Simon To is right to state “Chi-Med’;s consistent strategy over the past 16 years has generated considerable shareholder value" - to the tune of 2000% However, I think he is also right to suggest that if you think that is astonishing, you ain't seen nothing yet! The CEO said recently they were working on 2 or 3 big things any one of which will radically change 2017 guidance. That suggests a major Big Pharma licencing deal is on the cards like the recent Beigene/Celgene one announced 2 weeks ago, prompting Beigene's share price to go up 75%	nerdofsteel	Read Full Thread Reply

Chat Pages: 43 42 41 40 39 38 37 36 35 34 33 32 Older